This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| American Society of Gene & Cell Therapy | |
|---|---|
| Name | American Society of Gene & Cell Therapy |
| Abbreviation | ASGCT |
| Formation | 1996 |
| Type | Professional society |
| Headquarters | Not specified |
| Location | United States |
| Leader title | President |
| Website | Not included |
American Society of Gene & Cell Therapy is a professional organization focused on translational research in gene therapy and cell therapy, engaging researchers, clinicians, industry leaders, and regulators to advance therapeutic development. The society connects stakeholders across academic institutions, biotechnology firms, regulatory agencies, and philanthropic foundations to accelerate clinical applications and policy frameworks. It serves as a nexus among investigators, professional associations, and international consortia to shape research priorities, ethical standards, and public outreach.
The society was founded in the mid-1990s amid a surge of interest following milestones such as the completion of the Human Genome Project, the rise of genetic engineering in biotechnology companies like Genentech and Amgen, and clinical advances at institutions including National Institutes of Health, Mayo Clinic, Massachusetts General Hospital, Johns Hopkins Hospital, and Stanford University Medical Center. Early leaders included investigators affiliated with University of Pennsylvania, Children's Hospital of Philadelphia, University of California, San Francisco, Columbia University Irving Medical Center, and Memorial Sloan Kettering Cancer Center, alongside industry figures from Biogen and Novartis. The organization responded to events such as the 1999 death of a patient in a gene therapy trial at University of Pennsylvania and regulatory discussions at the U.S. Food and Drug Administration and the European Medicines Agency, prompting emphasis on safety and oversight. Over time the society collaborated with groups like International Society for Stem Cell Research, American Association for the Advancement of Science, American Society of Clinical Oncology, Pediatric Academic Societies, and global consortia tied to initiatives by World Health Organization and Bill & Melinda Gates Foundation.
The society's mission aligns with translational goals championed by institutions such as National Cancer Institute, National Heart, Lung, and Blood Institute, Howard Hughes Medical Institute, Wellcome Trust, and European Molecular Biology Laboratory. Objectives include promoting research standards used by investigators at Harvard Medical School, Yale School of Medicine, University of Cambridge, Imperial College London, and Karolinska Institutet, fostering regulatory dialogue with Centers for Medicare & Medicaid Services, Office of Biotechnology Activities, and strengthening partnerships with patient organizations like Cystic Fibrosis Foundation, Muscular Dystrophy Association, and Leukemia & Lymphoma Society. The society emphasizes ethical frameworks referenced by scholars at Oxford University, Princeton University, and King's College London, and supports workforce development similar to programs at Cold Spring Harbor Laboratory and Salk Institute.
Membership draws clinical investigators from Cleveland Clinic, Vanderbilt University Medical Center, and University of Pittsburgh Medical Center; basic scientists from Broad Institute, Scripps Research, and Whitehead Institute; and executives from companies like Regeneron, Moderna, Gilead Sciences, Roche, and Pfizer. Governance structures mirror models used by American Medical Association, Royal Society, and National Academy of Sciences, with elected officers, board members, and committee chairs who have affiliations spanning University of California, Berkeley, Cornell University, Duke University School of Medicine, University of Michigan, and University of Texas Southwestern Medical Center. Committees liaise with regulatory bodies including U.S. Department of Health and Human Services and international partners such as European Commission and Canadian Institutes of Health Research.
Annual meetings attract presenters from European Society of Gene and Cell Therapy, International Society for Cell & Gene Therapy, and academic centers like University of Pennsylvania Perelman School of Medicine, Columbia University, UCSF, Mount Sinai Health System, and Northwestern University Feinberg School of Medicine. Scientific sessions feature topics pioneered at labs such as Broad Institute, MIT Koch Institute, Francis Crick Institute, Max Planck Institute, and Riken. Workshops and symposia often include regulators from FDA, EMA, and speakers from philanthropic funders like Wellcome Trust and Howard Hughes Medical Institute, and highlight collaborations with patient advocates from AARP, American Cancer Society, and disease-specific groups like Alzheimer's Association.
The society disseminates research and policy analyses through peer-reviewed outlets and communications networks linked to journals and publishers such as Nature, Science, Cell, The Lancet, New England Journal of Medicine, Molecular Therapy, Journal of Clinical Investigation, Blood, and Gene Therapy. It issues position statements and white papers echoing analyses from think tanks like Brookings Institution and Center for Strategic and International Studies, and maintains newsletters and social media engagement similar to professional societies including American Society for Microbiology and American Heart Association. Educational materials reference protocols and resources developed at Addgene, Benchling, Protocols.io, and major repositories like GenBank and European Nucleotide Archive.
Advocacy efforts engage lawmakers and agencies including United States Congress, Office of Management and Budget, Department of Commerce, and international policymakers at European Parliament and United Nations. Policy priorities reflect concerns articulated by patient groups such as American Diabetes Association and Parkinson's Foundation, and interface with reimbursement frameworks in discussions involving Centers for Medicare & Medicaid Services and private payers like Blue Cross Blue Shield. The society contributes to regulatory guidance in coordination with FDA Center for Biologics Evaluation and Research and consults on international harmonization with organizations like International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.
Awards honor scientific achievements in gene and cell therapy akin to prizes given by Lasker Foundation, Breakthrough Prize, Warren Alpert Foundation, and Royal Society. Recipients often include investigators affiliated with Johns Hopkins University, Stanford University, University of Pennsylvania, Karolinska Institutet, and Cold Spring Harbor Laboratory, and sometimes mirror laureates from institutions recognized by Nobel Prize committees and major funders such as Gordon and Betty Moore Foundation and Wellcome Trust.